Novo Nordisk A/S (NVO)
USD 105.96
(-1.9%)
USD 105.96
(-1.9%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 232.26 Billion | 176.95 Billion | 140.8 Billion | 126.94 Billion | 122.02 Billion | 111.83 Billion |
| Cost of Revenue | 35.76 Billion | 28.44 Billion | 23.65 Billion | 20.93 Billion | 20.08 Billion | 17.61 Billion |
| Gross Profit | 196.49 Billion | 148.5 Billion | 117.14 Billion | 106.01 Billion | 101.93 Billion | 94.21 Billion |
| Operating Expenses | 93.92 Billion | 73.69 Billion | 58.49 Billion | 51.88 Billion | 49.45 Billion | 46.96 Billion |
| Selling, General and Administrative Expenses | 61.59 Billion | 50.68 Billion | 41.05 Billion | 36.88 Billion | 35.83 Billion | 33.31 Billion |
| Research and Development Expenses | 32.44 Billion | 24.04 Billion | 17.77 Billion | 15.46 Billion | 14.22 Billion | 14.8 Billion |
| Other Expenses | -119 Million | -1.03 Billion | -332 Million | -460 Million | -600 Million | -1.15 Billion |
| Cost and Expenses | 129.68 Billion | 102.14 Billion | 82.15 Billion | 72.82 Billion | 69.53 Billion | 64.58 Billion |
| Operating Income | 102.57 Billion | 74.8 Billion | 58.64 Billion | 54.12 Billion | 52.48 Billion | 47.24 Billion |
| Interest Expense | 542 Million | 378 Million | 2.45 Billion | 390 Million | 220 Million | 85 Million |
| Income Tax Expense | 20.99 Billion | 13.53 Billion | 11.32 Billion | 10.99 Billion | 9.6 Billion | 8.98 Billion |
| Earnings before Tax | 104.67 Billion | 69.06 Billion | 59.08 Billion | 53.13 Billion | 48.55 Billion | 47.61 Billion |
| Net Income | 83.68 Billion | 55.52 Billion | 47.75 Billion | 42.13 Billion | 38.95 Billion | 38.62 Billion |
| Earnings Per Share Basic | 18.62 | 12.26 | 10.40 | 9.03 | 8.20 | 7.98 |
| Earnings Per Share Diluted | 18.62 | 12.22 | 10.37 | 9.00 | 8.19 | 7.97 |
| Weighted Average Shares Outstanding | 4.49 Billion | 4.53 Billion | 4.59 Billion | 4.66 Billion | 4.74 Billion | 4.83 Billion |
| Weighted Average Shares Outstanding (Diluted) | 4.49 Billion | 4.54 Billion | 4.6 Billion | 4.68 Billion | 4.75 Billion | 4.84 Billion |
| Gross Margin | 0.85 | 0.84 | 0.83 | 0.84 | 0.84 | 0.84 |
| EBIT Margin | 0.49 | 0.46 | 0.48 | 0.47 | 0.47 | 0.46 |
| Profit Margin | 0.36 | 0.31 | 0.34 | 0.33 | 0.32 | 0.35 |
| EBITDA | 114.62 Billion | 82.04 Billion | 65.39 Billion | 59.27 Billion | 57.79 Billion | 51.17 Billion |
| Earnings Before Tax Margin | 0.44 | 0.42 | 0.42 | 0.43 | 0.43 | 0.42 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 68.06 Billion | 65.34 Billion | 232.26 Billion | 65.86 Billion | 58.73 Billion | 54.3 Billion |
| Cost of Revenue | 10.27 Billion | 9.91 Billion | 35.76 Billion | 10.01 Billion | 9.71 Billion | 7.85 Billion |
| Gross Profit | 57.78 Billion | 55.43 Billion | 196.49 Billion | 55.84 Billion | 49.01 Billion | 46.44 Billion |
| Operating Expenses | 32.25 Billion | 23.01 Billion | 93.92 Billion | 29.08 Billion | 22.1 Billion | 22.55 Billion |
| Selling, General and Administrative Expenses | 16.09 Billion | 14.41 Billion | - | 18.62 Billion | 14.07 Billion | 15.41 Billion |
| Research and Development Expenses | 16.16 Billion | 8.6 Billion | - | 10.46 Billion | 8.12 Billion | 7.12 Billion |
| Other Expenses | -405 Million | - | - | - | - | - |
| Cost and Expenses | 42.53 Billion | 32.93 Billion | 129.68 Billion | 39.09 Billion | 31.81 Billion | 30.41 Billion |
| Operating Income | 25.52 Billion | 32.41 Billion | 102.57 Billion | 26.76 Billion | 26.91 Billion | 23.88 Billion |
| Interest Expense | 1.56 Billion | 2.07 Billion | 542 Million | -2.1 Billion | 2.16 Billion | 281 Million |
| Income Tax Expense | 5.28 Billion | 6.51 Billion | 20.99 Billion | 5.65 Billion | 5.58 Billion | 4.82 Billion |
| Earnings before Tax | 25.33 Billion | 31.91 Billion | 104.67 Billion | 27.62 Billion | 28.06 Billion | 24.25 Billion |
| Net Income | 20.05 Billion | 25.4 Billion | 83.68 Billion | 21.96 Billion | 22.47 Billion | 19.42 Billion |
| Earnings Per Share Basic | 4.50 | 5.70 | - | 4.92 | 5.02 | 4.33 |
| Earnings Per Share Diluted | 4.49 | 5.68 | - | 4.91 | 5.01 | 4.31 |
| Weighted Average Shares Outstanding | 4.45 Billion | 4.45 Billion | 4.48 Billion | 4.46 Billion | 4.47 Billion | 4.49 Billion |
| Weighted Average Shares Outstanding (Diluted) | 4.46 Billion | 4.47 Billion | 4.49 Billion | 4.47 Billion | 4.48 Billion | 4.5 Billion |
| Gross Margin | 0.85 | 0.85 | 0.85 | 0.85 | 0.83 | 0.86 |
| EBIT Margin | 0.51 | 0.54 | - | 0.43 | 0.56 | 0.49 |
| Profit Margin | 0.29 | 0.39 | 0.36 | 0.33 | 0.38 | 0.36 |
| EBITDA | 34.37 Billion | 35.32 Billion | - | 28.51 Billion | 32.75 Billion | 26.71 Billion |
| Earnings Before Tax Margin | 0.38 | 0.50 | 0.44 | 0.41 | 0.46 | 0.44 |
PLY
TAVHL
NPACY
BDRXF
0HQ3
KWS